eHealth Inc

EHTH is in a Stage 4 decline with confirmed lower highs and lower lows, trading below declining EMAs that act as resistance. Medium-term asymmetry remains bearish, and short-term timing is bearish as price tightly tracks under sloping EMAs. Execution should occur now via a rejection at the 9/20/50 EMA cluster. A sustained close and acceptance above the EMA zone and a subsequent higher swing high would invalidate this bearish medium-term bias.

• ↑Lifetime advisory model launched to drive higher retention and upsells
• ↑Operating cash flow improved by $36M y/y, now –$5M vs –$41.2M
• ↓Q2 revenue collapsed 45% y/y to $33.6M on lower Medicare Advantage volume